KIT and gastrointestinal stromal tumor: In our early study, activated Hippo signaling/YAP-TAZ positively regulated cyclin D1 protein overexpression in KIT-independent GIST cells (Ou et al., 2019), and in the current report bortezomib treatment co-targeted expression of YAP/TAZ and cyclin D1 transcripts and proteins.